DOI QR코드

DOI QR Code

The Differences of Metabolic Syndrome Risk Factors according to Obesity and Abdominal Obesity in Elderly Korean Women

한국 노인여성의 비만, 복부비만 기준에 따른 대사증후군 위험요인의 차이

  • Shin, Kyung-A (Department of Clinical Laboratory Science, Shinsung University)
  • Received : 2016.10.17
  • Accepted : 2016.11.23
  • Published : 2016.12.31

Abstract

The study was performed to examine the metabolic syndrome risk factors in accordance with the obesity types based on body mass index (BMI) and waist circumference cutoffs. The diagnosis of metabolic syndrome closely adhered to the NCEP-ATP III criteria, and obesity was defined using the WHO Asian-Pacific criteria. We used the data from 591 elderly women, all aged over 65 years. They were divided into four groups: The normal group (n=272), the obesity group (n=124), abdominal obesity group (n=19), and obesity-abdominal obesity group (n=176). The obesity-abdominal obesity group was the most prevalent group of low HDL-cholesterol (p=0.009), hypertriglyceridemia (p=0.025), abdominal obesity (p<0.001), and metabolic syndrome (p<0.001). Logistic regression analysis demonstrated that the obesity-abdominal obesity group had the highest odds ratio in predicting metabolic syndrome (OR: 10.638, 95% CI: 6.053~18.697). Therefore, the obesity-abdominal obesity group was the strongest predictive factor of metabolic syndrome risk in Korean elderly women.

이 연구는 노인여성을 대상으로 비만, 복부비만 기준에 따른 대사증후군 위험요인의 차이를 알아보고, 비만 유형과 대사증후군 위험요인과의 관련성을 규명하고자 하였다. 비만 기준은 세계보건기구 아시아 태평양 기준에서 제시한 비만 기준을 따랐으며, 대사증후군은 The National Cholesterol Education Program Adult Treatment Panel III (NCEP-ATP III)의 진단기준에 따라 분류하였다. 연구 대상자 591명 중 정상군 272명, 단순비만군 124명, 복부비만군 19명, 비만-복부비만군 176명 이었다. 비만, 복부비만 기준에 따른 대사증후군 위험요인의 유병률 차이를 비교한 결과 낮은 HDL-콜레스테롤혈증(p=0.009), 고중성지방혈증(p=0.025), 복부비만(p<0.001), 대사증후군 진단 유병률(p<0.001)은 집단간 차이를 보였으며, 비만-복부비만군에서의 유병률이 높게 나타났다. 로지스틱 회귀분석을 통해 복부비만 기준에 따른 비만유형과 대사증후군 각각의 위험요인 및 대사증후군 진단간의 관련성을 분석한 결과, 정상군에 비해 단순비만군에서 낮은 HDL-콜레스테롤혈증의 발생이 1.6배 높았으며(odds ratio, OR: 1.576, 95% confidence interval, 95% CI: 1.006~2.469), 비만-복부비만군에서는 1.9배 높은 양상을 보였다(OR: 1.882, 95% CI: 1.266~2.799). 고중성 지방혈증은 정상군보다 비만-복부비만군에서 1.9배 높았다(OR: 1.904, 95% CI: 1.246~2.910). 또한 정상군보다 복부비만군에서 대사증후군 발생이 6.6배 높았으며(OR: 6.579, 95% CI: 2.233~19.385), 비만-복부비만군의 경우 10.6배 높은 양상을 보였다(OR: 10.638, 95% CI: 6.053~18.697).

Keywords

References

  1. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988;37(12):1595-1607. https://doi.org/10.2337/diab.37.12.1595
  2. Kim MK, Park JH. Metabolic syndrome. J Korean Med Assoc. 2012;55(10):1005-1013. https://doi.org/10.5124/jkma.2012.55.10.1005
  3. Byun JS, Kim MJ, Hwang YW, Kim MJ, Kim SY, Hwang IH. The usefulness of waist/height ratio as an obesity index. J Korean Acad Fam Med. 2004;25(4):307-313.
  4. Trifiro G, Alacqua M, Corrao S, Tari M, Arcoraci V. Statins for the primary prevention of cardiovascular events in elderly patients: a picture from clinical practice without strong evidence from clinical trials. J Am Geriatr Soc. 2008;56(1):175-177. https://doi.org/10.1111/j.1532-5415.2007.01486.x
  5. Sundquist K, Qvist J, Johansson SE, Sundquist J. Increasing trends of obesity in Sweden between 1996/97 and 2000/01. Int J Obes Relat Metab Disord. 2004;28(2):254-261. https://doi.org/10.1038/sj.ijo.0802553
  6. Lim JW, Kim SY, Ke SS, Cho BL. The prevalence of obesity, abdominal obesity and metabolic syndrome among elderly in general population. Korean J Fam Med. 2011;32(2):128-134. https://doi.org/10.4082/kjfm.2011.32.2.128
  7. Pasquali R, Casimirri F, Labate AM, Tortelli O, Pascal G, Anconetani B, et al. Body weight, fat distribution and the menopausal status in women. The VMH Collaborative Group. Int J Obes Related Metab Disord. 1994;18(9): 614-621.
  8. Sowers MF, Zheng H, Tomey K, Karvonen-Gutierrez C, Jannausch M, Li X, et al. Changes in body composition in women in women over six years at midlife: ovarian and chronological aging. J Clin Endocrinol Metab. 2007;92(3): 895-901. https://doi.org/10.1210/jc.2006-1393
  9. Lindheim SR, Buchanan TA, Duffy DM, Vijod MA, Kojima T, Stanczyk FZ, et al. Comparison of estimates of insulin sensitivity in pre- and postmenopausal women using the insulin tolerance test and the frequently sampled intravenous glucose tolerance test. J Soc Gynecol Investig. 1994;1(2):150-154. https://doi.org/10.1177/107155769400100210
  10. Carr MC. The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab. 2003;88(6):2404-2411. https://doi.org/10.1210/jc.2003-030242
  11. Gorodeski GI. Impact of the menopause on the epidemiology and risk factors of coronary artery heart disease in women. Exp Gerontol. 1994;29(3-4):357-375. https://doi.org/10.1016/0531-5565(94)90017-5
  12. Ferranini E, Barrett EJ, Bevilacqua S, DeFronzo RA. Effects of fatty acids on glucose production and utilization in man. J Clin Invest. 1983;72(5):1737-1747. https://doi.org/10.1172/JCI111133
  13. Abate N. Insulin resistance and obesity. The role of fat distribution. Diabetes care. 1996;19(3):292-294, https://doi.org/10.2337/diacare.19.3.292
  14. Woo J, Ho SC, Yu AL, Sham A. Is waist circumference a useful measure in predicting health outcomes in the elderly? Int J Obes Relat Metab Disord. 2002;26(10):1349-1355. https://doi.org/10.1038/sj.ijo.0802080
  15. Lee YS, Lee HJ, Oh JY, Hong YS, Sung YA. Sex hormone binding globulin, body fat distribution and insulin resistance in premenopausal women. J Korean Diabetes Assoc. 2003;27(1):63-72.
  16. Yi YH, Jung DW, Lee JG, Kim YJ, Lee SY, et al. Usefulness of sagittal abdominal diameter for evaluation of metabolic syndrome and insulin resistance. Korean J Fam Med. 2011;32(1):46-55. https://doi.org/10.4082/kjfm.2011.32.1.46
  17. McKeigue PM, Shah B, Marmot MG. Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet. 1991;337(8738):382-386. https://doi.org/10.1016/0140-6736(91)91164-P
  18. Wang J, Thornton JC, Burastero S, Shen J, Tanenbaum S, et al. Comparisons for body mass index and body fat percent among Puerto Ricans, blacks, whites and Asians living in the New York City area. Obesity research. 1996;4(4):377-384. https://doi.org/10.1002/j.1550-8528.1996.tb00245.x
  19. Shiwaku K, Anuurad E, Enkhmaa B, Kitajima K, Yamane Y. Appropriate BMI for Asian populations. Lancet. 2004;363(9414):1077.
  20. World Health Organization. The Asia-Pacific Perspective: Redefining obesity and its treatment. Sydney, Australia: Health Communications Australia Pty Ltd; 2000. p19-20.
  21. Lee S, Park HS, Kim SM, Kwon HS, Kim DY, Kim DJ, et al. Cut-off points of waist circumference for defining abdominal obesity in the Korean population. Korean J Obes. 2006;15(1):1-9.
  22. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486-2497. https://doi.org/10.1001/jama.285.19.2486
  23. James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel member appointed to the Eighth Joint National Committee (JNC8). JAMA. 2014;311(5):507-520. https://doi.org/10.1001/jama.2013.284427
  24. Choi EY. Comparison of fasting glucose and hemoglobin A1c for diagnosing diabetes in Korean Adults. Korean J Health Promot. 2010;10(4):162-168.
  25. Committee for Guidelines for Management of Dyslipidemia. 2015 Korean guidelines for management of dyslipidemia. J Lipid Atheroscler. 2015;4(1):61-92. https://doi.org/10.12997/jla.2015.4.1.61
  26. Moon K, Sung SH, Chang YK, Park IK, Paek YM, Kim SG, et al. The association between apolipoprotein E genotype and lipid profiles in healthy woman workers. J Prev Med Public Health. 2010;43(3):213-221. https://doi.org/10.3961/jpmph.2010.43.3.213
  27. Haslam D, James W. Obesity. Lancet. 2005;366(9492):1197-1209. https://doi.org/10.1016/S0140-6736(05)67483-1
  28. Rexrode K, Carey V, Henneken C. Walters E, Colditz G, Stampfer M, et al. Abdominal adiposity and coronary heart disease in women. JAMA. 1998;280(21):1843-1848. https://doi.org/10.1001/jama.280.21.1843
  29. Zhu S, Wang Z, Heshka S, Heo MS, Faith M, Heymsfield S. Waist circumference and obesity-associated risk factors among whites in the third National Health and Nutrition Examination Survey: clinical action thresholds. Am J Clin Nutr. 2002;76(4):743-749. https://doi.org/10.1093/ajcn/76.4.743
  30. International Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome [cited 2005 April 14]. Available from: http://www.idf.org/webdata/ docs/metabolicsyndrome_definition.pdf.
  31. Jassen I. Katzmarzyk P, Ross R. Waist circumference and not body mass index explains obesity-related health risk. Am J Clin Nutr. 2004;79(3):379-384. https://doi.org/10.1093/ajcn/79.3.379
  32. Jassen I. Katzmarzyk P, Ross R. Body mass index, waist circumference, and health risk: evidence in support of current National Institutes of Health guidelines. Arch Intern Med. 2002;162(18):2074-2079. https://doi.org/10.1001/archinte.162.18.2074
  33. Lee YE, Park JE, Hwang JY, Kim WY. Comparison of health risks according to the obesity types based upon BMI and waist circumference in Korean adults: The 1998-2005 Korean National Health and Nutrition Examination Surveys. Korean J Nutr. 2009;42(7):631-638. https://doi.org/10.4163/kjn.2009.42.7.631
  34. Fujioka S, Matsuzawa Y, Tokunaga K, Tarui S. Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity. Metabolism. 1987;36(1):54-59. https://doi.org/10.1016/0026-0495(87)90063-1
  35. Kook SR, Park YS, Ko YK, Kim SM, Lee DJ, Kang HC. Relationship of body fat, lipid, blood pressure, glucose in serum to waist-hip ratio between obese and normal body mass index group. J Korean Acad Fam med. 1997;18(3):317-327.